Status:
UNKNOWN
Kinetics of the Finasteride Prostate Induced Apoptosis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
40-90 years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate the mechanisms involved in the apoptosis induced by a treatment of finasteride on benign prostate hyperplasia (BPH). Five sets of patients who need a surgical proc...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with low tract urinary symptoms needing a surgical procedure
- No previous treatment with finasteride
- No androgen deficiency; no prostate cancer suspected.
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00130767
Start Date
December 1 2004
Last Update
April 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier Lyon Sud
Pierre-Bénite, France, 69495